Biliary tract cancers: addressing healthcare disparities and improving access to innovative treatments in Europe

Boilève, Alice; Neuzillet, Cindy; Turpin, Anthony; TIAN, TIAN

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Boilève, Alice
dc.contributor.author	Neuzillet, Cindy
dc.contributor.author	Turpin, Anthony
dc.contributor.author	TIAN, TIAN
dc.date.accessioned	2025-09-19T11:11:38Z
dc.date.available	2025-09-19T11:11:38Z
dc.date.issued	2025-03
dc.identifier.citation	Turpin A, Tian TV, Boilève A, Neuzillet C. Biliary tract cancers: addressing healthcare disparities and improving access to innovative treatments in Europe. Lancet Reg Heal - Eur. 2025 Mar;50:101215.
dc.identifier.issn	2666-7762
dc.identifier.uri	http://hdl.handle.net/11351/13692
dc.description	Biliary tract cancers: Disparities; Healthcare
dc.language.iso	eng
dc.publisher	Elsevier
dc.relation.ispartofseries	The Lancet Regional Health - Europe;50
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	Conductes biliars - Càncer - Tractament
dc.subject	Quimioteràpia combinada
dc.subject	Assistència sanitària
dc.subject.mesh	Bile Duct Neoplasms
dc.subject.mesh	/therapy
dc.subject.mesh	Cholangiocarcinoma
dc.subject.mesh	Healthcare Disparities
dc.subject.mesh	Antineoplastic Combined Chemotherapy Protocols
dc.title	Biliary tract cancers: addressing healthcare disparities and improving access to innovative treatments in Europe
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1016/j.lanepe.2025.101215
dc.subject.decs	neoplasias de los conductos biliares
dc.subject.decs	/terapia
dc.subject.decs	colangiocarcinoma
dc.subject.decs	disparidades en la atención sanitaria
dc.subject.decs	protocolos de quimioterapia antineoplásica combinada
dc.relation.publishversion	https://doi.org/10.1016/j.lanepe.2025.101215
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Turpin A] CHU Lille, University of Lille, Medical Oncology Department, Lille, France. CNRS INSERM UMR9020-U1277, CANTHER Cancer Heterogeneity Plasticity and Resistance to Therapies, Université de Lille, Lille, France. [Tian TV] Upper GI and Endocrine Tumor Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Boilève A] Gustave Roussy, Département de Médecine, Villejuif, France. INSERM U1279, Gustave Roussy, Villejuif, France. Université Paris Saclay, Orsay, France. [Neuzillet C] Gastrointestinal Oncology, Medical Oncology Department, Institut Curie, Université Versailles Saint-Quentin-Université Paris-Saclay, Saint-Cloud, France. Hepato-Gastroenterology Department, Ambroise Pare University Hospital, APHP, Boulogne-Billancourt, France. Molecular Oncology, PSL Research University, CNRS, UMR 144, Institut Curie, Paris, France
dc.identifier.pmid	40093394
dc.identifier.wos	001439126300001
dc.relation.projectid	info:eu-repo/grantAgreement/ES/PEICTI2021-2023/PID2023-146827OB-I00
dc.relation.projectid	info:eu-repo/grantAgreement/ES/PE2017-2020/RYC2020-029098-I
dc.rights.accessrights	info:eu-repo/semantics/openAccess